XILIO Trademark

Trademark Overview

On Thursday, February 17, 2022, a trademark application was filed for XILIO with the United States Patent and Trademark Office. The USPTO has given the XILIO trademark a serial number of 97271397. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, September 25, 2024. This trademark is owned by XILIO DEVELOPMENT, INC. CORPORATION. The XILIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer, all of the foregoing excluding pharmaceutical products for sleep disorders, central nervous disorders other than cancers of the central nervous system, and neurological disorders other than cancers of the neurological system
xilio

General Information

Serial Number97271397
Word MarkXILIO
Filing DateThursday, February 17, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of cancer, all of the foregoing excluding pharmaceutical products for sleep disorders, central nervous disorders other than cancers of the central nervous system, and neurological disorders other than cancers of the neurological system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXILIO DEVELOPMENT, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameXILIO DEVELOPMENT, INC. CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Friday, December 2, 2022LETTER OF SUSPENSION E-MAILED
Monday, February 21, 2022NEW APPLICATION ENTERED
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 2, 2022ASSIGNED TO EXAMINER
Friday, December 2, 2022SUSPENSION LETTER WRITTEN
Friday, December 2, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 20, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, January 9, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, January 10, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 10, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, January 10, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 10, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, January 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 5, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, June 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 29, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 29, 2023SOU EXTENSION 1 FILED
Friday, September 29, 2023SOU EXTENSION 1 GRANTED
Tuesday, October 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 27, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 27, 2024SOU EXTENSION 2 FILED
Wednesday, March 27, 2024SOU EXTENSION 2 GRANTED
Thursday, March 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2024SOU EXTENSION 3 GRANTED
Wednesday, September 25, 2024SOU EXTENSION 3 FILED

Related Keywords

xilio disorders other nervous than cancers neurological system central pharmaceutical products